| Literature DB >> 30838976 |
Martin Wegner1, Valentina Diehl1, Verena Bittl1,2, Rahel de Bruyn1, Svenja Wiechmann1,3, Yves Matthess1, Marie Hebel1, Michael Gb Hayes4, Simone Schaubeck1, Christopher Benner4, Sven Heinz4, Anja Bremm1,2, Ivan Dikic1,2,5,6, Andreas Ernst1,3, Manuel Kaulich1,5,6.
Abstract
Current technologies used to generate CRISPR/Cas gene perturbation reagents are labor intense and require multiple ligation and cloning steps. Furthermore, increasing gRNA sequence diversity negatively affects gRNA distribution, leading to libraries of heterogeneous quality. Here, we present a rapid and cloning-free mutagenesis technology that can efficiently generate covalently-closed-circular-synthesized (3Cs) CRISPR/Cas gRNA reagents and that uncouples sequence diversity from sequence distribution. We demonstrate the fidelity and performance of 3Cs reagents by tailored targeting of all human deubiquitinating enzymes (DUBs) and identify their essentiality for cell fitness. To explore high-content screening, we aimed to generate the largest up-to-date gRNA library that can be used to interrogate the coding and noncoding human genome and simultaneously to identify genes, predicted promoter flanking regions, transcription factors and CTCF binding sites that are linked to doxorubicin resistance. Our 3Cs technology enables fast and robust generation of bias-free gene perturbation libraries with yet unmatched diversities and should be considered an alternative to established technologies.Entities:
Keywords: 3Cs technology; CRISPR/Cas; DUBs; Doxorubicin; cell biology; gRNA library; genetics; genome-wide; genomics; human
Mesh:
Substances:
Year: 2019 PMID: 30838976 PMCID: PMC6424562 DOI: 10.7554/eLife.42549
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140